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Background: Resting electrocardiogram (ECG) shows limited sensitivity and specificity for the detection of 
coronary artery disease (CAD), where patients with a history of coronary revascularization may pose special 
challenges. Several methods exist to enhance sensitivity and specificity of resting ECG for diagnosis of CAD, but 
such methods are not better than a specialist’s judgement. We compared a new computer-enhanced, resting ECG 
analysis device, 3DMP, to coronary angiography to evaluate the device’s accuracy in detecting hemodynamically 
relevant CAD. 
Methods: A convenience sample of 172 patients with a history of coronary revascularization scheduled for 
coronary angiography was evaluated with 3DMP before coronary angiography. 3DMP's sensitivity and 
specificity in detecting hemodynamically relevant coronary stenosis as diagnosed with coronary angiography 
were calculated as well as odds ratios for the 3DMP severity score and coronary artery disease risk factors. 
Results: The 3DMP system accurately identified 50 of 55 patients as having hemodynamically relevant stenosis 
(sensitivity 90.9%, specificity 88.0%). Positive and negative predictive values for the identification of coronary 
stenosis as diagnosed in coronary angiograms were 62.7% and 97.8% respectively. Risk and demographic factors 
in a logistic regression model had a markedly lower predictive power for the presence of coronary stenosis in 
these patients than did 3DMP severity score (odds ratio 2.04 [0.74-5.62] vs. 73.57 [25.10-215.68]). A logistic 
regression combining severity score with risk and demographic factors did not add significantly to the prediction 
quality (odds ratio 80.00 [27.03-236.79]). 
Conclusions: 3DMP’s computer-based, mathematically derived analysis of resting two-lead ECG data provides 
detection of hemodynamically relevant CAD in patients with a history of coronary revascularization with high 
sensitivity and specificity that appears to be at least as good as those reported for other resting and/or stress ECG 
methods currently used in clinical practice. 
Key words: coronary artery disease, electrocardiography, computer-enhanced, coronary imaging: angiography, sensitivity, 
specificity, post-intervention 
Introduction 
Coronary artery disease (CAD) is the leading 
single cause of death in the developed world. Between 
15% and 20% of all hospitalizations are the direct 
results of CAD [1]. 
Revascularization of coronary arteries is one of 
the most frequently performed medical interventions 
in the developed world. In 2002, more than 500,000 
coronary artery bypass graft (CABG) surgeries and 
nearly 1.2 million percutaneous coronary interventions 
(PCI) including coronary stent implantations were 
performed in the US. In the same year, more than 
200,000 CABGs and more than half a million PCI were 
done in Europe [1]. Coronary restenosis after PCI and 
bypass graft and de-novo coronary stenosis are not 
infrequent after revascularization and remain 
significant clinical issues [2]. For example, studies of 
drug eluting and non-drug eluting stents show 
restenosis rates between 4% and over 20% [3, 4]. 
Coronary angiography remains the gold standard 
for the morphologic diagnosis of CAD and also allows 
revascularization during the same procedure [5,  6]. 
However, it is resource-intensive, expensive, invasive, 
and bears a relevant procedure-related complication 
rate (< 2%), morbidity (0.03-0.25%), and mortality 
(0.01-0.05%) [7,8]. 
Electrocardiography-based methods are routinely Int. J. Med. Sci. 2008, 5 
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used as the first tools for initial screening and 
diagnosis. Still, in clinical studies they show 
sensitivities for prediction of CAD of only 20% to 70% 
[9,10]. Even exercise ECG is an insensitive method to 
detect restenosis, with a sensitivity of below 55%. 
Therefore, the usefulness of ECG-based methods in the 
follow-up period after revascularization therapy has 
been questioned [11, 12, 13].  
Risk factors for CAD such as smoking, arterial 
hypertension, diabetes mellitus, obesity, or 
hypercholesterolemia (of which at least one is present 
in the vast majority of symptomatic CAD patients) can 
also be used to screen for hemodynamically relevant 
coronary stenosis [14, 15, 16, 17]. But in patients after 
coronary revascularization these risk factors are often 
modified by secondary prevention and have not been 
well validated for establishing pre-test probability of 
coronary stenosis.  
Several methods have been proposed and 
developed to enhance sensitivity and specificity of 
resting ECG for diagnosis of symptomatic and 
asymptomatic CAD. Yet such diagnostic ECG 
computer programs have not been shown to be equal 
or superior to the specialist physician’s judgment [18]. 
Moreover, studies comparing computerized with 
manual ECG measurements in patients with acute 
coronary syndrome have shown that computerized 
measurements have diagnostic cut-offs that differ from 
manual measurements and may not be used 
interchangeably [19]. This is likely one reason 
underlying the limited acceptance of such techniques 
in clinical practice during the follow-up period after 
coronary revascularization. 
The present study compared 3DMP, a new 
computer-enhanced, resting ECG device, to coronary 
angiography to evaluate 3DMP’s relevance in 
detecting coronary restenosis, graft stenosis, or de 
novo stenosis after coronary revascularization.  
Methods and Materials 
The study was approved by the local institutional 
committee on human research. Written informed 
consent was waived by each participant as a result of 
the disclosed non-risk designation of the study device. 
All patients received a full explanation and gave verbal 
consent to the study and the use of their de-identified 
data. 
Patients 
Between July 01, 2001, and June 30, 2003, 213 
patients scheduled for coronary angiography at the 
Heart Center Siegburg, Siegburg, Germany, were 
included in the study. These patients represented a 
convenience sample in that each patient was already 
scheduled for coronary angiography for any indication 
and had undergone at least one coronary 
revascularization procedure at least 6 weeks prior to 
the scheduled angiography. Thirty-six patients had a 
history of myocardial infarction (MI) more than six 
weeks prior to angiography. No patients presented 
with acute coronary syndrome at the time of study. 
Seven patients were excluded from the final analysis 
due to poor ECG tracing quality, and risk factor 
information could not be retrieved for 34 patients. The 
patient population did not overlap with any previous 
study or with the actual 3DMP database. The 3DMP 
reference database was not modified or updated 
during the study period. 
Medical history and risk factors for each patient 
were retrieved from the standard medical 
documentation. The following risk factors were 
classified as “present” or “not present” [14, 15, 16, 17]: 
•  Arterial hypertension (systolic blood pressure > 
140 mmHg and/or diastolic blood pressure > 90 
mmHg), 
•  Diabetes mellitus of any type, 
•  Hypercholesterolemia (cholesterol > 200 mg/dl or 
LDL-cholesterol > 160 mg/dl) and/or 
hypertriglyceridemia (triglycerides > 200 mg/dl), 
•  Active or former smoking (cessation less than 5 
years prior to inclusion in the study), 
•  Obesity (BMI > 30 kg/m2), 
•  Family history (symptomatic CAD of one parent), 
•  Other risk factors, including established diagnosis 
of peripheral artery disease. 
Study device 
The study device, 3DMP (Premier Heart, LLC, 
Port Washington, NY, USA), records a 2-lead resting 
ECG from leads II and V5 for 82 seconds each using 
proprietary hardware and software. The analog ECG 
signal is amplified, digitized, and down-sampled to a 
sampling rate of 100 Hz to reduce data transmission 
size; subsequent data transformations performed on 
the data do not require higher than 100 Hz/sec 
resolution. The digitized ECG data is encrypted and 
securely transmitted over the Internet to a central 
server. 
At the server, a series of Discrete Fourier 
Transformations are performed on the data from the 
two ECG leads followed by signal averaging. The final 
averaged digital data segment is then subjected to six 
mathematical transformations (power spectrum, 
coherence, phase angle shift, impulse response, 
cross-correlation, and transfer function) in addition to 
an amplitude histogram, all of which is used to Int. J. Med. Sci. 2008, 5 
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generate indexes of abnormality. The resulting 
patterns of the indexes are then compared for 
abnormality to the patterns in the reference database to 
reach a final diagnostic output. In addition to the 
automatic differential diagnosis and based on the 
database comparison, a severity score from 0 to 20 is 
calculated that indicates the level of myocardial 
ischemia (if present) resulting from coronary disease. 
The database against which the incoming ECG 
results are compared originated from data gathering 
trials conducted from 1978 to 2000 in more than 30 
institutions in Europe, Asia, and North America on 
individuals of varying ages and degrees of disease 
state including normal populations [20,21]. All ECG 
analyses in this database have been validated against 
the final medical diagnosis of at least two independent 
expert diagnosticians in the field, including results of 
angiography and enzyme tests. The current diagnostic 
capability for identification of local or global ischemia 
and the disease severity score used in this clinical 
study are based on 3DMP’s large proprietary database 
of validated ECG analyses accumulated since 1998. 
One important difference between 3DMP and 
other ECG methods is that the ECG is locally recorded 
but remotely analyzed at a central data facility due to 
the size and complexity of the reference database. A 
detailed description of the 3DMP technology was 
given previously in this journal [22].  
ECG acquisition and processing 
3DMP tests were conducted as follows by a 
trained trial site technician as part of a routine 
electrophysiological workup received by each patient 
prior to angiography. 
Patients were tested while quietly lying supine 
following 20 minutes of bed rest. 
Five ECG wires with electrodes were attached 
from the 3DMP machine to the patient at the four 
standard limb lead and precordial lead V5 positions. 
An automatic 82-second simultaneous two-lead 
(leads V5 and II) ECG sample was acquired with 
amplification and digitization. 
During the sampling, the ECG tracings displayed 
on the 3DMP screen were closely monitored for tracing 
quality. 
The digital data was then de-identified, 
encrypted, and sent via a secure Internet connection to 
www.premierheart.com. A second identical copy of 
the data was saved on the remote 3DMP machine for 
post-study verification purposes before the data 
analysis was carried out. The quality of the tracing was 
visually rechecked and graded as “good,” “marginal,” 
or “poor.” A poor tracing was defined by one of the 
following: 
•  five or more 5.12-second segments of ECG data 
contain idiopathic extrema that deviate from the 
baseline by ≥ 2 mm and appear ≥ 10 times,   
•  two or more 5.12-second segments of ECG data 
contain idiopathic extrema that deviate from the 
baseline by ≥ 5 mm, 
•  in a 25-mm section of waveform in any 
5.12-second segment of the ECG data, the 
waveform strays from the baseline by ≥ 3 mm, 
•  a radical deviation away from the baseline 80° of ≥ 
2 mm from the baseline, occurring two or more 
times, 
•  a single radical deviation away from the baseline 
80° episode of ≥ 5 mm from the baseline. 
A marginal tracing was defined by significant 
baseline fluctuations that did not meet the above 
criteria. Tracings consistently graded as poor after 
repeated sampling were excluded from the present 
study. All other tracings were included in the study.  
3DMP provided automatic diagnosis of regional 
or global ischemia, including silent ischemia, due to 
coronary artery disease, and calculated a severity 
score. This severity score has a maximum range from 0 
to 20 where a higher score indicates a higher likelihood 
of myocardial ischemia due to coronary stenosis. 
Following the 3DMP manufacturer’s recommendation, 
a cut-off of 4.0 for the severity score was used in this 
study, with a score of 4.0 or higher being considered 
indicative of a hemodynamically relevant coronary 
artery stenosis of >70% in at least one large-sized 
vessel. 
Angiographers and staff at the study site were 
blinded to all 3DMP findings. The 3DMP technicians 
and all Premier Heart staff were blinded to all clinical 
data including pre-test probabilities for CAD or 
angiography findings from the study patients. 
Retest reliability of 3DMP was assessed in 38 
patients on whom a second 3DMP test was done 
within 4 hours after the first test. The ECG electrodes 
were left in place for these repeat measurements. For 
comparison with angiography, the first test was 
always used in these patients. 
Angiography 
After the 3DMP test, coronary angiography was 
performed following the standards of the institution. 
Angiograms were classified immediately by the 
respective angiographer and independently by a 
second interventional cardiologist within 4 weeks after 
the angiogram. If the two investigators did not agree 
on the results, they discussed the angiograms until 
agreement was reached. Angiograms were classified as Int. J. Med. Sci. 2008, 5 
 
53
follows: 
Non-obstructive CAD: angiographic evidence of 
coronary arterial stenosis of ≤70% in a single or 
multiple vessels. Evidence included demonstrable 
vasospasm, delayed clearance of contrast medium 
indicating potential macro- or micro-vascular disease, 
documented endothelial abnormality (as indicated by 
abnormal contrast staining), or CAD with at least 40% 
luminal encroachment observable on angiograms. 
These patients were classified as negative for 
hemodynamically relevant CAD (= “stenosis: no”). 
Obstructive CAD: angiographic evidence of 
coronary arterial sclerosis of > 70% in a single or 
multiple vessels, with the exception of the left main 
coronary artery, where ≥50% was considered 
obstructive. These patients were classified as positive 
for hemodynamically relevant CAD (= “stenosis: yes”). 
The angiographic results represent the diagnostic 
endpoint against which 3DMP was tested. 
Statistical methods 
An independent study monitor verified the 
double-blindness of the study and the data integrity 
and monitored the data acquisition process, all 
angiography reports, and all 3DMP test results. 
Descriptive statistics were calculated for all variables 
(mean +/- standard deviation). Differences between 
two variables were tested with the t-test. Differences in 
2x2 tables were assessed for significance with Fisher’s 
exact test. Logistic regression was used to analyze 
effects of multiple categorical variables. Odds ratios 
including 95% confidence intervals were calculated. 
Sensitivity and specificity were calculated as were 
receiver operating characteristic (ROC) curves 
including an estimate of the area under the curve 
(AUC). Positive and negative predictive values (PPV, 
NPV) for the assessment of coronary stenosis were 
calculated with adjustment to prevalence of stenosis 
[23]. Moreover, in order to assess the performance of 
the prediction of stenosis independent of the 
prevalence of stenosis the positive and negative 
likelihood ratios (LR) were calculated [24]. A value of P 
< 0.05 was considered statistically significant. All 
analyses were done with SPSS for Windows Version 14 
(SPSS Inc., Chicago, IL, USA). 
Results 
Data from 172 of the original 213 patients were 
available for final analysis. The 41 patients excluded 
due to poor ECG tracings (7) or unavailability of full 
risk factor information (34) were not significantly 
different from the included patients with respect to age 
(63.7 +/-9.1 years vs. 63.9 +/- 10.0 years; p = 0.925), 
gender (29.3% female vs.32.6% male; p = 0.852), 
diagnosis of coronary stenosis (39% vs. 32%; p = 0.461), 
and type of revascularization procedure (CABG 41.5% 
CABG vs. 28.5%; p = 0.132). The study patients 
comprised 116 men and 56 women, with an average 
age of 63.9 +/- 10 years (35-83). Women were 
significantly older than men (68.7 +/- 8.2 years vs. 61.6 
+/- 9.9 years; p < 0.01). 
Forty-nine patients underwent CABG surgery 
and 123 PCI prior to angiography. Men undergoing 
PCI were significantly younger than men undergoing 
CABG (60.0 +/- 10 years vs. 64.7 +/- 9.2 years, p < 0.02; 
table 1). In the PCI patients, women were significantly 
older than men (69.3 +/-7.6 years vs. 60.0 +/-10 years, 
p < 0.01), whereas there was no significant age 
difference in the CABG patients (66.0 +/- 10.6 years vs. 
64.7 +/- 9.2 years, p = 0.725). 
Only 7 (4.1%) patients had no known risk factors 
for CAD, whereas 103 (59.9%) had at least three risk 
factors (table 1). Patients with arterial hypertension 
and with a family history of CAD were significantly 
older than those without; smokers were significantly 
younger than non-smokers (each p < 0.05). Diabetes 
was significantly more frequent in women (p < 0.05).  
Hemodynamically relevant coronary or graft 
stenosis was diagnosed by angiography in 55 patients 
(32%). There were no significant differences between 
men and women in the rate of stenosis. There were 
also no significant age differences between patients 
with and patients without stenosis (table 2). The 
percentage of angiographically identified stenosis was 
higher in the CABG group than in the PCI group, but 
not significantly (40.8% vs. 28.5%; p = 0.15). Of the 36 
patients with a history of myocardial infarction only 15 
(42%) had a hemodynamically relevant stenosis. The 
difference to patients without an MI history was not 
statistically significant. 
In a logistic regression model with all risk factors, 
age, gender, the type of revascularization procedure, 
only arterial hypertension was negatively associated 
with an increase in the risk of coronary stenosis (OR 
0.34 [0.16-0.72]; p < 0.01). A weak, but not significant, 
association could be seen with CABG (OR 1.86 
[0.88-3.93]; p = 0.10). With this model, 67.4% of all cases 
were correctly classified (OR 2.04 [0.74-5.62], summary 
in table 3). When history of MI was included in this 
model, the model did not significantly change. 
Specifically, history of MI was not a significant factor 
in this model. 
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Table 1: Risk factors, gender, age distribution, type of revascularization, and MI history. 
All Patients  Gender 
         female  male 
Age (years)      Age (years)      Age (years)     
 
Mean SD  N  %  Mean SD N  %  Mean SD  N  % 
no  61.0 10.3 44 25.6% 63.9  8.3 11 19.6%  60.1 10.9 33 28.4%  Arterial 
Hypertension 
yes  64.9 9.7  128  74.4%  69.8 7.9  45  80.4% 62.2 9.6 83  71.6% 
no  64.9 9.1 51  29.7%  70.2 9.5  14  25.0% 62.9 8.2 37  31.9%  High 
Cholesterol/Lipids  yes  63.4 10.3  121  70.3% 68.1  7.8 42 75.0%  60.9 10.6 79 68.1% 
no  66.2  9.9 105  61.0% 70.4  8.0 39 69.6%  63.7 10.1 66 56.9%  Active or Former 
Smoking  yes  60.3 9.0 67  39.0%  64.6 7.4  17  30.4% 58.8 9.1 50  43.1% 
no  63.5 10.2  131  76.2% 68.9  8.7 37 66.1%  61.3 10.0 94 81.0%  Diabetes of any 
type  yes  65.3  9.3  41 23.8% 68.2  7.5 19 33.9%  62.7 10.0 22 19.0% 
no  66.1 9.6  109  63.4%  71.5 8.0  32  57.1% 63.9 9.4 77  66.4%  Family History 
yes  60.0 9.4 63  36.6%  64.8 7.0  24  42.9% 57.0 9.6 39  33.6% 
no  64.5 9.5  100  58.1%  68.2 8.7  30  53.6% 63.0 9.5 70  60.3%  Obesity 
yes  63.0 10.6 72 41.9% 69.2  7.8 26 46.4%  59.5 10.4 46 39.7% 
no  63.8  10.0 168 97.7%  68.7  8.2  56 100.0%  61.4  10.0 112 96.6%  Other Risk Factors 
yes  66.5  7.0  4  2.3%            66.5  7.0  4  3.4% 
0  67.1  8.6  7  4.1%            67.1  8.6  7  6.0% 
1  66.7 9.3 20  11.6%  73.3 6.1 6 10.7% 63.8 9.1 14  12.1% 
2  64.7 10.3 42 24.4% 68.6  8.9 15 26.8%  62.6 10.6 27 23.3% 
3  62.8 10.4 54 31.4% 68.3 10.5  15 26.8%  60.7  9.7  39 33.6% 
4  66.8 8.9 22  12.8%  70.3 7.4  10  17.9% 63.9 9.3 12  10.3% 
5  59.1 8.7 20  11.6%  65.4 3.5 8 14.3% 54.8 8.7 12  10.3% 
Number of Risk 
Factors 
6  60.6  10.2  7 4.1% 63.0 1.4  2 3.6% 59.6  12.3  5 4.3% 
no  64.1 9.4  136  79.1%  68.2 8.2  46  82.1% 62.1 9.3 90  77.6%  Myocardial 
infarction in 
history 
yes  62.9 12.0 36 20.9% 70.8  8.7 10 17.9%  59.9 11.9 26 22.4% 
PCI  63.4 10.2  123  71.5% 69.3  7.6 45 80.4%  60.0 10.0 78 67.2%  Revascularization 
in Patient History  CABG 65.0  9.4  49 28.5% 66.0 10.6  11 19.6%  64.7  9.2  38 32.8% 
Table 2: Frequency of coronary stenosis, distribution of gender, age, type of revascularization, risk factors, and MI history. 
Coronary Stenosis   
no yes 
All Patients 
All Patients  Mean  63.9  63.9  63.9 
 Std  Deviation  9.5  11.0  10.0 
   N  117  55  172 
Gender female  Age  (years)  Mean  69.3  67.3  68.7 
         SD  7.7  9.5  8.2 
         N  39  17  56 
   male  Age (years)  Mean  61.2  62.4  61.6 
         SD  9.2  11.4  9.9 
         N  78  38  116 
Arterial Hypertension  no  N  22  22  44 
   yes  N  95  33  128 
High Cholesterol/Lipids  no  N  32  19  51 
   yes  N  85  36  121 
Active or Former Smoking  no  N  72  33  105 
   yes  N  45  22  67 
Diabetes of any type  no  N  89  42  131 
   yes  N  28  13  41 
Family History  no  N  73  36  109 
   yes  N  44  19  63 
Obesity no  N  68  32  100 
   yes  N  49  23  72 
Other Risk Factors  no  N  114  54  168 
   yes  N  3  1  4 
Number of Risk Factors  0  N  4  3  7 
   1  N  10  10  20 
   2  N  32  10  42 
   3  N  37  17  54 
   4  N  12  10  22 Int. J. Med. Sci. 2008, 5 
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Coronary Stenosis   
no yes 
All Patients 
   5  N  16  4  20 
   6  N  6  1  7 
Myocardial infarction in history  no  N  96  40  136 
   yes  N  21  15  36 
Revascularization in Patient History  PCI  N  88  35  123 
   CABG  N  29  20  49 
Table 3: Prediction of coronary stenosis by logistic regression with risk factors (“A”), by logistic regression with risk factors and MI 
history (“B”), by logistic regression with risk factors and severity score (cut-off 4.0; “C”), by logistic regression with risk factors and 
MI history and severity score (cut-off 4.0; “D”), and by severity score (cut-off 4.0; “E”) alone for total population, gender, age 
groups, type of revascularization, and MI history. 
OR 95% CI  ROC AUC 95% CI   n  TP TN FP FN a priori Correct Sens Spec PPV NPV LR+ LR- OR 
Lower Upper 
ROC 
AUC 
Lower Upper 
Total A  172  8  108  9  47  0.320  0.674  0.145 0.923 0.295 0.830 1.891 0.926 2.04  0.74  5.62  0.674  0.587  0.760 
  B 172 13 107 10 42  0.320  0.698  0.236 0.915 0.379 0.844 2.765 0.835 3.31  1.35  8.13  0.673  0.585  0.761 
  C 172 50 104 13  5  0.320  0.895  0.909 0.889 0.644 0.978 8.182 0.102 80.00 27.03  236.79 0.927  0.879  0.975 
  D 172 50 103 14  5  0.320  0.890  0.909 0.880 0.627 0.978 7.597 0.103 73.57 25.10  215.68 0.929  0.881  0.976 
   E 172 50 103 14  5  0.320  0.890  0.909 0.880 0.627 0.978 7.597 0.103 73.57 25.10  215.68 0.903  0.855  0.952 
Female A  56  7  35  4  10  0.304  0.750  0.412 0.897 0.433 0.889 4.015 0.655 6.13  1.49  25.22  0.730  0.586  0.874 
 B  56  7  35  4  10  0.304  0.750  0.412 0.897 0.433 0.889 4.015 0.655 6.13  1.49  25.22  0.731  0.588  0.873 
 C  56  14  34  5  3  0.304  0.857  0.824 0.872 0.550 0.963 6.424 0.202 31.73 6.66  151.14  0.920  0.843  0.997 
 D  56  14  36  3  3  0.304  0.893  0.824 0.923 0.670 0.965 10.706 0.191 56.00 10.08  311.25  0.937  0.874  0.999 
   E  56  15  33  6  2  0.304  0.857  0.882 0.846 0.521 0.974 5.735 0.139 41.25 7.44  228.70  0.882  0.793  0.971 
Male A  116  7  72  6  31  0.328  0.681  0.184 0.923 0.362 0.827 2.395 0.884 2.71  0.84  8.72  0.668  0.564  0.772 
 B  116  10  71  7  28  0.328  0.698  0.263 0.910 0.410 0.839 2.932 0.809 3.62  1.25  10.46  0.688  0.585  0.792 
 C  116  35  70  8  3  0.328  0.905  0.921 0.897 0.681 0.980 8.980 0.088 102.08 25.49  408.85  0.936  0.883  0.990 
 D  116  35  70  8  3  0.328  0.905  0.921 0.897 0.681 0.980 8.980 0.088 102.08 25.49  408.85  0.936  0.882  0.990 
   E 116 35  70  8  3  0.328  0.905  0.921 0.897 0.681 0.980 8.980 0.088 102.08 25.49  408.85  0.914  0.856  0.973 
< 65 years  A  93  7  58  5  23  0.323  0.699  0.233 0.921 0.400 0.841 2.940 0.833 3.53  1.02  12.26  0.703  0.591  0.814 
 B  93  11  57  6  19  0.323  0.731  0.367 0.905 0.466 0.863 3.850 0.700 5.50  1.79  16.89  0.721  0.604  0.838 
 C  93  27  57  6  3  0.323  0.903  0.900 0.905 0.682 0.976 9.450 0.111 85.50 19.86  368.01  0.918  0.843  0.993 
 D  93  27  57  6  3  0.323  0.903  0.900 0.905 0.682 0.976 9.450 0.111 85.50 19.86  368.01  0.915  0.839  0.991 
   E  93  27  57  6  3  0.323  0.903  0.900 0.905 0.682 0.976 9.450 0.111 85.50 19.86  368.01  0.929  0.868  0.990 
> 65 years  A  79  4  49  5  21  0.316  0.671  0.160 0.907 0.270 0.834 1.728 0.926 1.87  0.46  7.65  0.701  0.579  0.823 
 B  79  4  49  5  21  0.316  0.671  0.160 0.907 0.270 0.834 1.728 0.926 1.87  0.46  7.65  0.706  0.587  0.825 
 C  79  20  51  3  5  0.316  0.899  0.800 0.944 0.755 0.957 14.400 0.212 68.00 14.84  311.50  0.957  0.912  1.001 
 D  79  19  51  3  6  0.316  0.886  0.760 0.944 0.746 0.948 13.680 0.254 53.83 12.22  237.11  0.958  0.916  1.001 
   E  79  20  51  3  5  0.316  0.899  0.800 0.944 0.755 0.957 14.400 0.212 68.00 14.84  311.50  0.875  0.796  0.953 
PCI A  123  12  81  7  23  0.285  0.756  0.343 0.920 0.405 0.899 4.310 0.714 6.04  2.13  17.10  0.680  0.565  0.795 
 B  123  12  81  7  23  0.285  0.756  0.343 0.920 0.405 0.899 4.310 0.714 6.04  2.13  17.10  0.677  0.561  0.793 
 C  123  30  80  8  5  0.285  0.894  0.857 0.909 0.599 0.976 9.429 0.157 60.00 18.19  197.92  0.909  0.839  0.980 
 D  123  29  81  7  6  0.285  0.894  0.829 0.920 0.622 0.971 10.416 0.186 55.93 17.36  180.20  0.913  0.847  0.980 
   E 123 30  79  9  5  0.285  0.886  0.857 0.898 0.570 0.975 8.381 0.159 52.67 16.33  169.90  0.897  0.835  0.959 
CABG A  49  7  25  4  13  0.408  0.653  0.350 0.862 0.547 0.736 2.538 0.754 3.37  0.83  13.64  0.711  0.560  0.862 
 B  49  7  24  5  13  0.408  0.633  0.350 0.828 0.491 0.728 2.030 0.785 2.58  0.68  9.79  0.691  0.537  0.844 
 C  49  19  27  2  1  0.408  0.939  0.950 0.931 0.868 0.975 13.775 0.054 256.50 21.67  3035.99  0.991  0.973  1.008 Int. J. Med. Sci. 2008, 5 
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OR 95% CI  ROC AUC 95% CI   n  TP TN FP FN a priori Correct Sens Spec PPV NPV LR+ LR- OR 
Lower Upper 
ROC 
AUC 
Lower Upper 
 D  49  20  28  1  0  0.408  0.980  1.000 0.966 0.932 1.000 29.000 0.000 NaN NaN  NaN  0.999  0.996  1.003 
   E  49  20  24  5  0  0.408  0.898  1.000 0.828 0.734 1.000 5.800 0.000 n/a  n/a  n/a  0.905  0.816  0.995 
No MI in history A 136  6  93  3  34  0.294  0.728  0.150 0.969 0.455 0.868 4.800 0.877 5.47  1.30  23.10  0.667  0.564  0.769 
 C  136  35  86  10  5  0.294  0.890  0.875 0.896 0.593 0.976 8.400 0.140 60.20 19.19  188.83  0.925  0.868  0.981 
   E 136 35  85  11  5  0.294  0.882  0.875 0.885 0.570 0.976 7.636 0.141 54.09 17.51  167.12  0.884  0.821  0.946 
MI in history  A  36  9  17  4  6  0.417  0.722  0.600 0.810 0.616 0.799 3.150 0.494 6.38  1.42  28.60  0.819  0.681  0.957 
 C  36  14  20  1  1  0.417  0.944  0.933 0.952 0.909 0.966 19.600 0.070 280.00 16.12  4863.44  0.994  0.977  1.010 
 E  36  15  18  3  0  0.417  0.917  1.000 0.857 0.781 1.000 7.000 0.000 NaN NaN  NaN  0.957  0.898  1.016 
n = number of cases; TP = true positives; TN = true negatives; FP = false positives; FN = false negatives; a priori = a priori probability of 
stenosis; Correct = fraction of correctly predicted cases; Sens = sensitivity; Spec = specificity; PPV = positive predictive value; NPV = negative 
predictive value; LR+ = positive likelihood ratio; LR- = negative likelihood ratio; OR = odds ratio; ROC AUC = receiver operating curve area 
under the curve (for continuous severity score and probabilities from logistic regression models); 95% CI = 95% confidence interval; Lower = 
Lower boundary of 95% CI; Upper = Upper boundary of 95% CI; NaN = Not a number; MI = Myocardial infarction; PCI = percutaneous 
coronary intervention; CABG = coronary artery bypass grafting 
 
The severity score ranged from 0 to 11.5, mean 2.9 
(+/-2.8), with 62.8% of all patients having a severity 
score of less than 4. The severity score was 
significantly higher for patients with relevant coronary 
stenosis as diagnosed at angiography than for patients 
without stenosis (5.6 +/- 2.1 vs. 1.7 +/-2.2; p < 0.01; 
Figure 1). For the association between severity score 
and coronary stenosis, the area under the ROC curve 
was calculated to be 0.903 [0.855-0.952] (Figure 2). The 
coordinates of the curve indicated that a cut-off of 4.0 
provided the best combination of sensitivity and 
specificity for the prediction of coronary stenosis from 
the 3DMP test (as was pre-defined by the 
manufacturer). 
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Figure 1. Severity score versus coronary stenosis as diagnosed 
by angiography. Boxplots of severity score. Circles denote 
outliers. 
Patients without coronary stenosis had a severity 
score below 4.0 significantly more frequently than 
those with stenosis (p < 0.01), with 89% of all cases 
being correctly classified (OR 73.57 [25.10-215.68]). The 
results listed in table 4 indicate a sensitivity of 90.9% 
and specificity of 88% for the 3DMP test in the 
prediction of coronary stenosis (positive predictive 
value = 0.627, negative predictive value = 0.978). A 
positive likelihood ratio of over 7 and a negative 
likelihood ratio of 0.1 indicate a good to strong 
diagnostic value for this test (Table 3). 
Sensitivity and specificity did not vary 
significantly between gender, age groups, or type of 
revascularization, although sensitivity was especially 
high in patients after CABG, and specificity in older 
patients (Table 3). Analysis of ROC also showed that 
for each subgroup, the best cut-off was 4.0 (Figure 2).  
In a logistic regression model, the addition of all 
risk factors did not significantly improve the 
classification of coronary stenosis (89.5% correct; OR 
80.00 [27.03-236.79]). When information about MI 
history was added to this model again the 
classification, performance did not change markedly 
(89% correct; OR 73.57 [25.10-215.68]. 
The ROC AUC for a regression model with all 
risk factors, all risk factors plus information about MI 
history, the severity score alone, a regression model 
with the severity score plus all risk factors, and a 
regression model with the severity score plus all risk 
factors and information about MI history were 0.674 
[0.587-0.760], 0.673 [0.585-0.761], 0.903 [0.855-0.952], 
0,927 [0.879-0.975], and 0.929 [0.881-0.976] respectively 
(Figure 3). Similar results could be found for each 
gender and age group (Table 3). Int. J. Med. Sci. 2008, 5 
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Figure 2. ROC curves for severity score for the detection of 
coronary stenosis for different gender, age groups, and type of 
revascularization. yoa = years of age. 
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Figure 3. ROC curves of severity score alone (“SC”), risk 
factors (logistic regression model, “RF”), risk factors and MI 
history (logistic regression, “RF + MI”), risk factors plus 
severity score (logistic regression model, “SC + RF”), and risk 
factors plus severity score and MI history (logistic regression 
model, “SC + RF+ MI”), for detecting coronary stenosis. 
 
Table 4: Prediction of coronary stenosis by severity score 
(cut-off 4.0). 
    Prediction Cut-off 4.0 
      no stenosis  stenosis 
Total 
103 14  117  no 
59.9% 8.1%  68.0% 
5 50  55 
Coronary Stenosis 
yes 
2.9% 29.1%  32.0% 
   108 64  172  Total 
   62.8% 37.2%  100.0% 
 
 
 
 
If patients with history of MI were excluded the 
diagnostic performance of 3DMP did not change 
significantly with 88.2% of these patients correctly 
classified (details in Table 3).   
To further evaluate performance of 3DMP, 
sensitivity and specificity were assessed at different 
cut-offs for severity (Table 5). This comparison also 
showed that a cut-off of 4.0 provided the best 
compromise of sensitivity and specificity. As the 
negative predictive value at a cut-off of 4.0 is already 
high and increases only slightly with lower cut-offs, a 
value of 4.0 may also be suitable for screening in this 
patient population. 
A second 3DMP test was performed on 38 
patients within 4 hours of the first test and before 
angiography. The test results were identical in 32 
patients. In only 1 patient was the difference in 
severity scores greater than 1 and in only 2 patients 
would this difference have led to a change in 
classification (4.0 and 3.0 for the first test, 3.0 and 4.0 
for the second test).  
Verification after the end of the data acquisition 
confirmed that locally stored and transmitted ECG 
data were identical for all recordings. 
 
Table 5: Prediction of coronary stenosis by severity score at different cut-offs for total population (n = 172, a priori probability of 
stenosis = 0.372). 
OR 95% CI   TP  TN  FP  FN  a 
priori 
Correct Sens Spec PPV NPV LR+ LR-  OR 
Lower Upper 
Cut-Off  2.0  53  65  52  2  0.320  0.686  0.964 0.556 0.324 0.986 2.168 0.065 33.13  7.71  142.37 
Cut-Off  2.5  53  78  39  2  0.320  0.762  0.964 0.667 0.390 0.988 2.891 0.055 53.00  12.27  228.95 
Cut-Off  3.0  51  83  34  4  0.320  0.779  0.927 0.709 0.414 0.978 3.191 0.103 31.13  10.43  92.87 
Cut-Off  3.5  50  93  24  5  0.320  0.831  0.909 0.795 0.495 0.975 4.432 0.114 38.75  13.93  107.78 
Cut-Off  4.0  50  103  14  5  0.320  0.890  0.909 0.880 0.627 0.978 7.597 0.103 73.57  25.10  215.68 Int. J. Med. Sci. 2008, 5 
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OR 95% CI   TP  TN  FP  FN  a 
priori 
Correct Sens Spec PPV NPV LR+ LR-  OR 
Lower Upper 
Cut-Off  4.5  43  104  13  12  0.320  0.855  0.782 0.889 0.609 0.949 7.036 0.245 28.67  12.11  67.83 
Cut-Off  5.0  33  107  10  22  0.320  0.814  0.600 0.915 0.608 0.912 7.020 0.437 16.05  6.91  37.30 
TP = true positives; TN = true negatives; FP = false positives; FN = false negatives; correct = fraction of correctly predicted cases; Sens = 
sensitivity; Spec = specificity; PPV = positive predictive value; NPV = negative predictive value; OR = odds ratio; 95% CI = 95% confidence 
interval; Lower = Lower boundary of 95% CI; Upper = Upper boundary of 95% CI 
 
Discussion 
The age and gender distributions in the studied 
patient group match those of patients with 
symptomatic coronary artery disease reported in the 
literature [25]. Also the distribution between 
post-CABG and post-PCI patients corresponds to the 
official numbers reported for these procedures in most 
developed countries [1]. The incidence of clinically 
identified risk factors for CAD among the studied 
patients was high across the entire study group. The 
calculated relative risks for symptomatic CAD 
resulting from the risk factors in the study group is in 
the range of what is reported in the literature from 
larger epidemiologic studies [14, 15, 16, 17]. 
The overall sensitivity of 90.9% and specificity of 
88% of the 3DMP device are in line with results from a 
study of 3DMP in patients with CAD but without 
previous revascularization done at the same center in 
parallel [22]. Similar performance was also reported 
from another earlier study, although the results were 
based on a quantitative assessment of ischemia by the 
3DMP system [21]. The quantitative severity score 
used in the current study was not available at that 
time. 
Resting ECG analysis, including that of the 
12-lead ECG, typically has significantly less sensitivity 
in detecting ischemia. Clinical studies report a wide 
range of sensitivity from 20% to 70% for acute 
myocardial infarction (AMI) and typically less for 
hemodynamically significant CAD [9, 26]. 
Diagnostic yield from the ECG can be improved 
by exercise testing. Exercise ECG has a reported 
specificity of over 80% under ideal conditions. 
Clinically, however, the sensitivity is typically not 
better than 50-60% and shows significant gender bias 
[27, 28, 29, 30]. Performance of exercise ECG testing 
can further be enhanced by multivariate analysis of 
ECG and clinical variables. First studies into 
computerized, multivariate exercise ECG analysis 
showed good to excellent sensitivity in men and 
women (83% and 70%, respectively) and specificity 
(93%, 89%) [31, 32]. These results were confirmed by a 
second group of researchers [33] and are similar to our 
findings with 3DMP. Other researchers used different 
statistical approaches and models of multivariate 
stress ECG analysis with different sets of variables 
included in the models [34,  35,  36,  37]. While these 
approaches provided significantly better diagnostic 
performance than standard exercise ECG testing, it 
appears that none of these methods has been 
implemented in broad clinical practice or a commercial 
product. It should also be noted that none of the above 
studies included patients with previous coronary 
revascularization. 
In a comprehensive systematic review of 16 
prospective studies myocardial perfusion scintigraphy 
showed better positive and negative likelihood ratios 
than exercise ECG testing [38]. But wide variation 
between studies was reported with positive LR 
ranging from 0.95 to 8.77 and negative LR from 1.12 to 
0.09. Another review of stress scintigraphy studies 
showed similar results with a diagnostic accuracy of 
85% by wide variation between studies (sensitivity 
44%-89%, specificity 89%-94%, for 2+vessel disease) 
[39]. In one study the combination of stress ECG 
testing with myocardial scintigraphy using 
multivariate analysis provided only limited 
improvement of diagnostic accuracy [40].  
Stress echocardiography performed by 
experienced investigators may provide better 
sensitivity and specificity than does stress ECG. 
Numerous studies into exercise echocardiography as a 
diagnostic tool for CAD have been done. Reported 
sensitivities range from 31% to over 90% and 
specificities from 46% to nearly 100% [41, 42, 43]. With 
experienced investigators, sensitivities of over 70% 
and specificities better than 85% can be expected. 
While the reported diagnostic performance of 
stress echocardiography, myocardial scintigraphy and 
stress scintigraphy for the identification of patients 
with hemodynamically relevant coronary restenosis, 
graft stenosis or denovo stenosis seems to be similar to 
that we found for 3DMP, these imaging modalities can 
provide additional information such as spatial 
localization that the 3DMP method cannot. 
In contrast to the study in patients without 
previous revascularization from the same center there 
were no significant differences with respect to Int. J. Med. Sci. 2008, 5 
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sensitivity or specificity attributable to gender or age 
[22]. This may be due to selection effects, or just to the 
smaller sample size. 
The odds ratio for CAD was 2.04 [0.74-5.62] in a 
logistic regression model using the risk factors 
identified clinically in this patient group. This is less 
than in patients without previous revascularization in 
the same setting investigated with the same 
methodology [22]. But it is in concordance with large 
epidemiological studies, although these studies did 
not specifically investigate patients after coronary 
revascularization [14, 15, 16, 17]. Still, this model could 
predict coronary stenosis only with a sensitivity of 
14.5% which is markedly less than for the severity 
score. Adding all risk factors, gender, age, and type of 
revascularization to the severity score in a logistic 
regression model improved prediction of CAD only 
marginally (OR 73.57 [25.10-215.68] vs. OR 80.00 
[27.03-236.79]).  
The endpoint of this study was the morphological 
diagnosis of coronary restenosis, de-novo stenosis, or 
graft stenosis in coronary angiography, whereas the 
investigated electrophysiologic method (3DMP) 
assesses functional changes in electrical myocardial 
function secondary to changes in coronary blood flow. 
Therefore, even under ideal conditions a 100% 
coincidence between angiographic findings and 3DMP 
results could not be expected. This is probably true for 
every electrophysiologic diagnostic method.  
Resting and stress ECG in CAD patients 
primarily focuses on ST-segment analysis and the 
detection of other conduction abnormalities such as 
arrhythmias. This is not comparable to the 3DMP 
approach, which calculates a severity score for CAD 
from a complex mathematical analysis. A comparison 
between 3DMP, 12-lead resting ECG, and coronary 
angiography in another study showed a higher 
sensitivity and specificity for 3DMP than for 12-lead 
ECG in the detection of coronary stenosis [21]. 
One limitation of the present study was that the 
angiography results were not explicitly quantified 
using a scoring system [44]. Still, the assessment of 
coronary lesions in the study set forth herein was 
consistent between two experienced angiographers 
who independently evaluated the angiograms. 
Moreover, the relevance of morphological 
quantification of coronary stenosis in angiograms has 
been subject to discussion [45]. Because the target 
criterion was hemodynamic relevant coronary 
stenosis, subclinical or subcritical lesions may have 
been classified as non-relevant. This may have 
artificially reduced the calculated sensitivity and 
specificity of the 3DMP method. Another limitation of 
the study may have been patient recruitment. The 
patient population represented a convenience sample 
of revascularization patients from a larger group of 
consecutive patients scheduled for coronary 
angiography in a single heart center. While this may 
limit the generalizability of the patient sample used 
herein, the demographic distribution of this sample 
matches well with the distributions reported in the 
literature for patients with CAD as do the incidence 
and distribution of risk factors. Finally, 3DMP was 
compared in this study to angiography but not to any 
other non-invasive diagnostic technology. Therefore, 
inference about the potential superiority or inferiority 
of 3DMP in comparison to other ECG-based methods 
can only be drawn indirectly from other studies.  
In conclusion, the mathematical analysis of the 
ECG by 3DMP appears to provide sensitivity and 
specificity for the prediction of relevant restenosis, 
de-novo stenosis, and graft stenosis as diagnosed with 
coronary angiography in patients after coronary 
revascularization that is at least as good as that of 
standard resting or stress ECG test methods reported 
in other clinical studies. However, this impression 
needs to be further confirmed in a direct comparison 
between such methods.  
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